Skip to main content
logo
Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ: EPRX · Real-Time Price · USD
6.72
+0.05 (0.75%)
Aug 14, 2026, 4:00 PM EDT - Market closed

Eupraxia Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
4423811121115828
Market Cap Growth
126.02%241.41%0.65%90.50%111.19%-
Enterprise Value
33632210296438
Last Close Price
6.727.553.174.162.692.30

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
3.414.743.51124.328.081.83
P/TBV Ratio
4.357.2965.7050.067.481.75

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.010.000.0011.711.250.52
Net Debt / Equity Ratio
-1.02-1.00-1.04-9.96-1.29-1.04
Net Debt / EBITDA Ratio
2.322.101.230.320.531.12
Net Debt / FCF Ratio
3.452.761.100.430.631.31
Quick Ratio
15.7114.4410.741.016.0013.38
Current Ratio
16.0015.1211.101.026.0813.49
Return on Equity (ROE)
-66.70%-68.76%-157.31%-715.19%-178.04%-
Return on Assets (ROA)
-43.66%-39.67%-61.14%-88.37%-52.20%-68.51%
Return on Capital Employed (ROCE)
-43.50%-47.70%-84.80%-3120.70%-109.70%-61.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-11.64%-10.12%-22.84%-25.44%-31.75%-68.66%
FCF Yield
-8.65%-7.64%-26.96%-18.77%-25.12%-43.73%
Buyback Yield / Dilution
-47.78%-17.76%-40.52%-25.21%-55.45%-102.75%
SEC Filings: 10-K · 10-Q